Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 102,230 | 53,600 | 85,820 | 55,713 | 57,960 |
| Marketable Securities | N/A | N/A | N/A | 17,177 | 38,106 |
| Receivables | 1,604 | 6,667 | N/A | N/A | N/A |
| TOTAL | $108,994 | $67,755 | $92,665 | $79,446 | $101,537 |
| Non-Current Assets | |||||
| PPE Net | 22,945 | 24,571 | 26,294 | 28,083 | 29,904 |
| Investments And Advances | 1,400 | 1,400 | 1,400 | 0 | 0 |
| Other Non-Current Assets | 12,754 | 13,316 | 113 | 1,513 | 1,513 |
| TOTAL | $37,099 | $39,287 | $27,807 | $29,596 | $31,417 |
| Total Assets | $146,093 | $107,042 | $120,472 | $109,042 | $132,954 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,764 | 3,918 | 6,415 | 6,475 | 5,158 |
| Accrued Expenses | 10,589 | 11,789 | 15,207 | 14,634 | 13,651 |
| TOTAL | $43,073 | $41,569 | $42,041 | $39,010 | $36,771 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 7,685 | 8,119 |
| Deferred Revenues | 23,271 | 21,455 | 20,419 | 17,901 | 17,962 |
| Other Non-Current Liabilities | 18,628 | 19,710 | 644 | 1,129 | 1,129 |
| TOTAL | $120,988 | $135,306 | $126,476 | $100,597 | $109,438 |
| Total Liabilities | $164,061 | $176,875 | $168,517 | $139,607 | $146,209 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,496 | 2,055 | 2,052 | 2,043 | 2,040 |
| Common Shares | 70 | 41 | 41 | 41 | 40 |
| Retained earnings | -424,462 | -413,703 | -389,370 | -368,083 | -346,136 |
| Other shareholders' equity | 0 | 0 | 0 | -9 | -29 |
| TOTAL | $-17,968 | $-69,833 | $-48,045 | $-30,565 | $-13,255 |
| Total Liabilities And Equity | $146,093 | $107,042 | $120,472 | $109,042 | $132,954 |